Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2023 Sep 26

PMID 37751136

Authors

Lingling Fan

Khadka Sudeep

Jianfei Qi

Affiliations

Soon will be listed here.

Abstract

Methylation of histone H3 lysine 9 (H3K9) is a repressive histone mark and associated with inhibition of gene expression. KDM3 is a subfamily of the JmjC histone demethylases. It specifically removes the mono- or di-methyl marks from H3K9 and thus contributes to activation of gene expression. KDM3 subfamily includes three members: KDM3A, KDM3B and KDM3C. As KDM3A (also known as JMJD1A or JHDM2A) is the best studied, this chapter will mainly focus on the role of KDM3A-mediated gene regulation in the biology of normal and cancer cells. Knockout mouse studies have revealed that KDM3A plays a role in the physiological processes such as spermatogenesis, metabolism and sex determination. KDM3A is upregulated in several types of cancers and has been shown to promote cancer development, progression and metastasis. KDM3A can enhance the expression or activity of transcription factors through its histone demethylase activity, thereby altering the transcriptional program and promoting cancer cell proliferation and survival. We conclude that KDM3A may serve as a promising target for anti-cancer therapies.

Citing Articles

PCAT19: the role in cancer pathogenesis and beyond.

Hu H, Luo H, Deng Z Front Cell Dev Biol. 2025; 12:1435717.

PMID: 39744012 PMC: 11688190. DOI: 10.3389/fcell.2024.1435717.

References

Labbe R, Holowatyj A, Yang Z . Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential. Am J Transl Res. 2013; 6(1):1-15. PMC: 3853420. View

Zhan M, Wen F, Liu L, Chen Z, Wei H, Zhou H . JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells. Tumour Biol. 2016; 37(8):11237-47. DOI: 10.1007/s13277-016-4999-9. View

Parrish J, Sechler M, Winn R, Jedlicka P . The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma. Oncogene. 2013; 34(2):257-62. PMC: 4477825. DOI: 10.1038/onc.2013.541. View

Ohguchi H, Hideshima T, Bhasin M, Gorgun G, Santo L, Cea M . The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival. Nat Commun. 2016; 7:10258. PMC: 4728406. DOI: 10.1038/ncomms10258. View

Mosammaparast N, Shi Y . Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem. 2010; 79:155-79. DOI: 10.1146/annurev.biochem.78.070907.103946. View

Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R . Male development of chromosomally female mice transgenic for Sry. Nature. 1991; 351(6322):117-21. DOI: 10.1038/351117a0. View

Maes T, Carceller E, Salas J, Ortega A, Buesa C . Advances in the development of histone lysine demethylase inhibitors. Curr Opin Pharmacol. 2015; 23:52-60. DOI: 10.1016/j.coph.2015.05.009. View

Krivtsov A, Armstrong S . MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007; 7(11):823-33. DOI: 10.1038/nrc2253. View

Kim H, Kim D, Choi S, Rok Kim C, Oh S, Pyo K . KDM3A histone demethylase functions as an essential factor for activation of JAK2-STAT3 signaling pathway. Proc Natl Acad Sci U S A. 2018; 115(46):11766-11771. PMC: 6243239. DOI: 10.1073/pnas.1805662115. View

10.

Qi J, Nakayama K, Cardiff R, Borowsky A, Kaul K, Williams R . Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell. 2010; 18(1):23-38. PMC: 2919332. DOI: 10.1016/j.ccr.2010.05.024. View

11.

Kim S, Kim J, Choe N, Cho I, Kim J, Kim D . Regulation of mouse steroidogenesis by WHISTLE and JMJD1C through histone methylation balance. Nucleic Acids Res. 2010; 38(19):6389-403. PMC: 2965226. DOI: 10.1093/nar/gkq491. View

12.

Wade M, Jones D, Wilson L, Stockley J, Coffey K, Robson C . The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer. Nucleic Acids Res. 2014; 43(1):196-207. PMC: 4288188. DOI: 10.1093/nar/gku1298. View

13.

Peng K, Su G, Ji J, Yang X, Miao M, Mo P . Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling. J Biol Chem. 2018; 293(27):10606-10619. PMC: 6036217. DOI: 10.1074/jbc.RA118.001730. View

14.

Kuroki S, Matoba S, Akiyoshi M, Matsumura Y, Miyachi H, Mise N . Epigenetic regulation of mouse sex determination by the histone demethylase Jmjd1a. Science. 2013; 341(6150):1106-9. DOI: 10.1126/science.1239864. View

15.

Ebos J, Lee C, Cruz-Munoz W, Bjarnason G, Christensen J, Kerbel R . Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 2009; 15(3):232-9. PMC: 4540346. DOI: 10.1016/j.ccr.2009.01.021. View

16.

Fimia G, De Cesare D, Sassone-Corsi P . CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature. 1999; 398(6723):165-9. DOI: 10.1038/18237. View

17.

Buchheit C, Weigel K, Schafer Z . Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014; 14(9):632-41. DOI: 10.1038/nrc3789. View

18.

Mahajan K, Mahajan N . ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers. Oncogene. 2014; 34(32):4162-7. PMC: 4411206. DOI: 10.1038/onc.2014.350. View

19.

Kuroki S, Akiyoshi M, Tokura M, Miyachi H, Nakai Y, Kimura H . JMJD1C, a JmjC domain-containing protein, is required for long-term maintenance of male germ cells in mice. Biol Reprod. 2013; 89(4):93. DOI: 10.1095/biolreprod.113.108597. View

20.

Li Y, Alsagabi M, Fan D, Bova G, Tewfik A, Dehm S . Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression. Cancer Res. 2011; 71(6):2108-17. PMC: 3059379. DOI: 10.1158/0008-5472.CAN-10-1998. View